AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Purple Biotech Ltd.

Prospectus Jan 7, 2025

7004_rns_2025-01-07_474b8c47-60e6-4d39-aedd-980a2ce87592.htm

Prospectus

Open in Viewer

Opens in native device viewer

_________ false

���� ����� ��"� 2 352
PURPLE BIOTECH LTD
Corporation no: 520031238 12724
- - -
Israel Securities Authority Tel Aviv Stock Exchange C004 ( Public ) Reported via MAGNA: 06/01/2025
www.isa.gov.il www.tase.co.il Reference: 2025-02-001974 Time of broadcast: 23:56 23:56

Immediate report on other matterDon't use this form if there is more adequate one

PURPLE BIOTECH LTD PROSPECTUS SUPPLEMENT (to Prospectus Supplement dated October 17, 2023, to Prospectus dated May 22, 2023)
Attached file ea022682701-424b5_purpleEDGAR2_isa.pdf
PROSPECTUS SUPPLEMENT����� �
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 06/08/2024
Address: Oppenheimer, Science Park 4 , Rehovot 7670104   , Israel Tel: 03-9333121 , 03-9311321 Fax: 03-5097196
E-mail address: [email protected]   Company site: www.kitovpharma.com
Previous names of reporting entity: KITOV PHARMA LTD, KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,
Name of the Signatory: Masas Ludmer Adi Position of Signatory in the reporting corporation: Company Controller Name of Employer Company:
Address: Menachem Begin Drive 132 , Tel Aviv 6701101 Telephone: 03-9333121 Facsimile: 03-5097196 E-mail: [email protected] 1
Israel

Talk to a Data Expert

Have a question? We'll get back to you promptly.